Search Results - "Barton, F"

A New Vaccine to Battle Covid-19 by Haynes, Barton F

“…The United States and many parts of the world have now lost control of the Covid-19 pandemic owing to the respiratory spread of SARS-CoV-2 and to inconsistent…”
Get full text

HIV-1 neutralizing antibodies: understanding nature's pathways by Mascola, John R., Haynes, Barton F.

“…Summary The development of an effective vaccine has been hindered by the enormous diversity of human immunodeficiency virus‐1 (HIV‐1) and its ability to escape…”
Get full text

Ease of Acquisition: Deriving Critical Brain Perfusion Information from Conventional MRI Sequences by Branstetter, 4th, Barton F

Get full text

New approaches to HIV vaccine development by Haynes, Barton F

“…Highlights • New progress has been made in understanding effective protective mechanisms of anti-HIV CD8 cytolytic T lymphocytes. • New progress has been made…”
Get full text

SARS-CoV-2 and HIV-1 — a tale of two vaccines by Haynes, Barton F.

“…The rapid development of COVID-19 vaccines and their deployment in less than a year is a scientific and medical triumph that has raised a key question. Why do…”
Get full text

HIV Never Sleeps: Evidence to Support Early Antiretroviral Treatment by Haynes, Barton F

“…This Pillars of Immunology article is a commentary on “HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of…”
Get full text

Surveillance Imaging for Head and Neck Cancer: Some Much-needed Proof of Effectiveness by Branstetter, Barton F

Get full text

SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment by Li, Dapeng, Sempowski, Gregory D, Saunders, Kevin O, Acharya, Priyamvada, Haynes, Barton F

“…Prophylactic and therapeutic drugs are urgently needed to combat coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2…”
Get full text

Host controls of HIV broadly neutralizing antibody development by Kelsoe, Garnett, Haynes, Barton F.

“…Summary Induction of broadly neutralizing antibodies (bNAbs) is a major goal of HIV vaccine development. BNAbs are made during HIV infection by a subset of…”
Get full text

Author Correction: SARS-CoV-2 and HIV-1 – A Tale of Two Vaccines by Haynes, Barton F.

Get full text

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity by Gobeil, Sophie M-C, Janowska, Katarzyna, McDowell, Shana, Mansouri, Katayoun, Parks, Robert, Stalls, Victoria, Kopp, Megan F, Manne, Kartik, Li, Dapeng, Wiehe, Kevin, Saunders, Kevin O, Edwards, Robert J, Korber, Bette, Haynes, Barton F, Henderson, Rory, Acharya, Priyamvada

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with multiple spike mutations enable increased transmission and antibody resistance. We…”
Get full text

Latency reversal and viral clearance to cure HIV-1 by Margolis, David M., Garcia, J. Victor, Hazuda, Daria J., Haynes, Barton F.

“…Research toward a cure for human immunodeficiency virus type 1 (HIV-1) infection has joined prevention and treatment efforts in the global public health…”
Get full text

Controlling the SARS-CoV-2 spike glycoprotein conformation by Henderson, Rory, Edwards, Robert J., Mansouri, Katayoun, Janowska, Katarzyna, Stalls, Victoria, Gobeil, Sophie M. C., Kopp, Megan, Li, Dapeng, Parks, Rob, Hsu, Allen L., Borgnia, Mario J., Haynes, Barton F., Acharya, Priyamvada

“…The coronavirus (CoV) spike (S) protein, involved in viral–host cell fusion, is the primary immunogenic target for virus neutralization and the current focus…”
Get full text

Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines by Haynes, Barton F.

Get full text

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines by Shen, Xiaoying, Tang, Haili, McDanal, Charlene, Wagh, Kshitij, Fischer, William, Theiler, James, Yoon, Hyejin, Li, Dapeng, Haynes, Barton F., Sanders, Kevin O., Gnanakaran, Sandrasegaram, Hengartner, Nick, Pajon, Rolando, Smith, Gale, Glenn, Gregory M., Korber, Bette, Montefiori, David C.

“…All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of generating protective neutralizing antibodies. The recent emergence and…”
Get full text

Arrested Descent of the Thyroid: A New Manifestation of Abnormal Thyroid Embryology by Branstetter, Barton F., Fernandez, Annella

“…In this article, we review the normal embryology of the thyroid gland, categorize the ways in which this embryology can fail, and describe how those failures…”
Get full text

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction by Gobeil, Sophie M.-C., Janowska, Katarzyna, McDowell, Shana, Mansouri, Katayoun, Parks, Robert, Manne, Kartik, Stalls, Victoria, Kopp, Megan F., Henderson, Rory, Edwards, Robert J., Haynes, Barton F., Acharya, Priyamvada

“…The severe acute respiratory coronavirus 2 (SARS-CoV-2) spike (S) protein is the target of vaccine design efforts to end the coronavirus disease 2019…”
Get full text

HIV-Host Interactions: Implications for Vaccine Design by Haynes, Barton F., Shaw, George M., Korber, Bette, Kelsoe, Garnett, Sodroski, Joseph, Hahn, Beatrice H., Borrow, Persephone, McMichael, Andrew J.

“…Development of an effective AIDS vaccine is a global priority. However, the extreme diversity of HIV type 1 (HIV-1), which is a consequence of its propensity…”
Get full text

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization by Weissman, Drew, Alameh, Mohamad-Gabriel, de Silva, Thushan, Collini, Paul, Hornsby, Hailey, Brown, Rebecca, LaBranche, Celia C., Edwards, Robert J., Sutherland, Laura, Santra, Sampa, Mansouri, Katayoun, Gobeil, Sophie, McDanal, Charlene, Pardi, Norbert, Hengartner, Nick, Lin, Paulo J.C., Tam, Ying, Shaw, Pamela A., Lewis, Mark G., Boesler, Carsten, Şahin, Uğur, Acharya, Priyamvada, Haynes, Barton F., Korber, Bette, Montefiori, David C.

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein acquired a D614G mutation early in the pandemic that confers greater infectivity…”
Get full text

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice by Martinez, David R, Schäfer, Alexandra, Leist, Sarah R, De la Cruz, Gabriela, West, Ande, Atochina-Vasserman, Elena N, Lindesmith, Lisa C, Pardi, Norbert, Parks, Robert, Barr, Maggie, Li, Dapeng, Yount, Boyd, Saunders, Kevin O, Weissman, Drew, Haynes, Barton F, Montgomery, Stephanie A, Baric, Ralph S

“…The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2003 and SARS-CoV-2 in 2019 highlights the need to develop universal vaccination…”
Get full text